Lupin receives US FDA EIR with VAI classification for Goa facility
Inspection conducted in November 2025; Establishment Inspection Report issued by US regulator
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Zenex Animal Health acquires majority stake in Netherlands-based VievePharm
Transaction marks entry into global naturals market and sets up manufacturing and sales hub in Western Europe
Lupin ranked among top 1% globally in S&P Global Corporate Sustainability Assessment
Company scores 91 out of 100; included in Sustainability Yearbook 2026 for third consecutive year
Glenmark to launch Sodium Phosphates Injection USP single-dose vials in april 2026
Product bioequivalent to Hospira reference drug; IQVIA reports $66.8 million annual market sales
GSK survey flags Shingles impact and prevention gaps among adults with chronic conditions in India
Findings released ahead of Shingles Action Week show low awareness and limited doctor-patient discussions on risk and vaccination
Bayer secures India approval for expanded use of Nubeqa
Darolutamide plus ADT cleared for mHSPC, supported by ARANOTE Phase III data with Indian participation
Eli Lilly India launches obesity awareness campaign
Initiative positions obesity as a chronic disease and highlights role of doctors in evidence-based care
Alembic Pharmaceuticals receives USFDA approval for Lamotrigine Orally Disintegrating tablets
Company secures final approval for ANDA across four strengths; cumulative USFDA ANDA approvals reach 235
MSD appoints Brecht Vanneste as MD for India
Brecht Vanneste to take charge of MSD India operations from 1 March 2026, based in Mumbai
Zydus Lifesciences to launch Semaglutide Injection in India after patent expiry
Company plans rollout under SEMAGLYN, MASHEMA and ALTERME brands with adjustable single-pen device
B&R India hosts Innovations Day 2026 to showcase smart manufacturing solutions
Event highlights intelligent automation, industry collaboration, and next-generation motion control technologies
Biocon receives US FDA approval for Liraglutide Injection gSaxenda
Approval covers 18 mg/3 mL prefilled pens for chronic weight management in the United States
Lupin receives US FDA approval for Brivaracetam Oral Solution 10 mg/mL
Company initiates US launch following ANDA approval for bioequivalent to Briviact
Kiran Mazumdar-Shaw awarded Honorary Fellowship of the UK Academy of Medical Sciences
Biocon Group Chairperson recognised for contributions to biomedical science and access to medicines
DGFT rationalises RoDTEP scheme, reduces benefits by 50 per cent
Value caps under the scheme have also been reduced by 50 per cent wherever applicable
FDA reversal on Moderna’s mRNA-1010 can transform the seasonal influenza vaccines market: GlobalData
GlobalData highlights that the FDA’s review of Moderna’s mRNA-1010, with a 05 August 2026 PDUFA date, could introduce the first…
NIT Rourkela startup receives CDSCO approval for StopBleed Hemostat
Institute spinout Miraqules MedSolutions secures regulatory clearance for technology aimed at emergency haemorrhage control
Alembic Pharmaceuticals receives USFDA approval for Efinaconazole Topical Solution, 10%
Product is therapeutically equivalent to Jublia; company holds 234 USFDA ANDA approvals
US and Japan present narrower path for Alzheimer’s drug approvals: GlobalData
Only two monoclonal antibodies approved in both markets with no small molecules cleared
Eris Lifesciences partners Natco Pharma to commercialise Semaglutide in India
CDSCO approval enables planned March 2026 launch targeting Type 2 diabetes management